I was moved by this editorial on global health matters in a daily British newspaper by an academic medical colleague, written in response to anticipated changes in the leadership of the World Health Organisation. It is perhaps time for us surgeons to augment our administrative participation in global healthcare.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease
April 5, 2017
An international group of experts met at the 2017 STS Annual Meeting in Houston, Texas, to discuss the evolving practice of robotic and hybrid coronary revascularization.
March 28, 2017
The authors report here on the results of the Italian CHEETAH study, a randomized, double-blind, placebo-controlled trial examining whether adding the unique inotrope levosimendan—in low doses—improves 30-day mortality after cardiac surgery in patients with perioperative LV dysfunction.
March 27, 2017
The authors demonstrate how to perform a coronary artery bypass with a stented vein graft using a VEST device.
March 20, 2017
The authors randomized 68 patients undergoing CABG to three treatment groups:
March 5, 2017
The authors describe a 10-year experience with extended arteriotomy for endarterectomy of a diffusely diseased LAD, using an internal mammary artery for reconstruction. Perioperative mortality was 1.1% and postoperative MI occurred in 9%. Survival at 5 years was 89% and freedom from acute cardiovascular events was 74%.
March 5, 2017
This trial randomly assigned 4,752 patients from 19 countries to either on-pump or off-pump CABG with a mean follow-up of 4.8 years. The authors report no difference in death, stroke, myocardial infarction, renal failure or repeat revascularization at 5 years between the two groups.
February 23, 2017
Coronary and/or CT angiograms were performed on 585 of 762 (94%) patients at varying intervals after CABG using the PAS-Port System proximal anastomotic device. The authors retrospectively evaluated the SVG patency at a mean follow-up interval (between CABG and the diagnostic procedures) was 319 ± 624 days.
January 13, 2017
This article is a propensity matched analysis comparing patients undergoing hybrid coronary revascularization (HCR) with minimally invasive left internal mammary artery to left anterior descending artery (LAD) bypass and percutaneous coronary intervention (PCI) to non-LAD arteries to patients undergoing conventional coronary artery bypass grafting (C
January 5, 2017
This video demonstrates a long segment left anterior descending coronary endarterectomy with saphenous vein angioplasty and LIMA-LAD.